Edit
Target RWE Health Evidence Solutions
http://www.targetrwe.com/Last activity: 06.05.2024
Active
Target RWE is a leading health evidence solutions company that generates innovative real-world evidence (RWE) and provides scientific intelligence tools and solutions for pharmaceutical, biotechnology, and other healthcare partners.
Specifically designed to address the complexities of the natural history of disease, the drug development process and treatments in real-world settings, Target RWE builds regulatory-grade clinical data sets and applies state of the science epidemiologic methods to produce RWE about patients with specific conditions, symptoms, and therapies used in usual clinical practice.
Target RWE's regulatory-grade data sets and evidence, modern epidemiological methods, and sound scientific principles rendered as software can be utilized to better health outcomes, inform patient health guidelines, and improve overall quality of care.
Specifically designed to address the complexities of the natural history of disease, the drug development process and treatments in real-world settings, Target RWE builds regulatory-grade clinical data sets and applies state of the science epidemiologic methods to produce RWE about patients with specific conditions, symptoms, and therapies used in usual clinical practice.
Target RWE's regulatory-grade data sets and evidence, modern epidemiological methods, and sound scientific principles rendered as software can be utilized to better health outcomes, inform patient health guidelines, and improve overall quality of care.
Location: United States, North Carolina, Durham
Employees: 51-200
Founded date: 2015
Investors 1
| Date | Name | Website |
| - | Norwest Ve... | nvp.com |
Mentions in press and media 6
| Date | Title | Description |
| 06.05.2024 | Komodo Health & Partners Present 33 Real-World Evidence Research Studies at ISPOR 2024 | Researchers Used Komodo’s Healthcare Map to Uncover Insights Across Oncology, Women’s Health, Mental Health, Neurology, and more Komodo Insights Power Three Studies Named Finalists for ISPOR 2024 Research Presentation Awards SAN FRANCISCO &... |
| 11.01.2023 | Target RWE Launches 35 New Disease State Registries in Complex Indications with High Unmet Medical Needs and Rapidly Evolving Therapies | Company Additionally Announces Exclusive Biorepository Milestone of 10,000+ TARGET-DERM Samples DURHAM, N.C., Jan. 11, 2023 /PRNewswire/ -- Target RWE, the leader and largest provider of real-world evidence (RWE) in non-cancer conditions, a... |
| 30.09.2021 | Hepion Pharmaceuticals : ALL ENDPOINTS MET IN HEPION PHARMACEUTICALS' DRUG-DRUG INTERACTION STUDY WITH CRV431 | EDISON, N.J. - Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence ('AI')-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis ('NASH') ... |
| 29.09.2021 | Hepion Pharmaceuticals : All Endpoints Met in Hepion Pharmaceuticals' Drug-Drug Interaction Study with CRV431 (Form 8-K) | All Endpoints Met in Hepion Pharmaceuticals' Drug-Drug Interaction Study with CRV431 EDISON, N.J., September 29, 2021- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence... |
| 29.09.2021 | Hepion Pharmaceuticals : All Endpoints Met in Hepion Pharmaceuticals' Drug-Drug Interaction Study with CRV431 | EDISON, N.J., Sept. 29, 2021 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of non-a... |
| 15.01.2021 | Target RWE Acquires NoviSci | Target RWE, a Durham, NC-based real-world evidence (RWE) solutions company for the pharmaceutical and biotech industries, acquired NoviSci, Inc., a Durham-based software analytics and services company whose innovative technologies enable th... |